Natacha Gassenbach
Public Communications Contact bei BIOGEN INC.
Profil
Natacha Gassenbach is currently the Chief Communication Officer at Biogen, Inc. Prior to this, she held positions as Head of Corporate Affairs at Boston Scientific Corp., Baxalta, Inc., and Novartis Vaccines & Diagnostics, Inc. She also served as the Global Head of Communications & Investor Relations at Stallergenes Greer Ltd.
Gassenbach is a graduate of Sorbonne Université.
Aktive Positionen von Natacha Gassenbach
Unternehmen | Position | Beginn |
---|---|---|
BIOGEN INC. | Public Communications Contact | 01.10.2018 |
Ehemalige bekannte Positionen von Natacha Gassenbach
Unternehmen | Position | Ende |
---|---|---|
STALLERGENES GREER | Investor Relations Kontakt | 01.10.2018 |
BOSTON SCIENTIFIC CORPORATION | Public Communications Contact | - |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Public Communications Contact | - |
BAXALTA INC | Public Communications Contact | - |
Ausbildung von Natacha Gassenbach
Sorbonne Université | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BIOGEN INC. | Health Technology |
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Stallergenes Greer Ltd.
Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |